Seeking to widen access to hepatitis C treatments around the world, the Medicines Patent Pool and AbbVie (ABBV) signed a voluntary licensing deal in which the drug maker will allow a generic version of one of its medicines to be made and sold in dozens of countries. Yet the agreement is also being criticized for limiting availability compared with similar licensing arrangements that other companies have reached.

Specifically, AbbVie has agreed to provide its Mavyret hepatitis C pill to 99 low- and middle-income countries and territories through royalty-free arrangements with generic drug manufacturers. The arrangements will be facilitated by MPP, which is a nonprofit backed by the United Nations that works with drug makers to widen access to medicines.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I had Hep-c 1 for something like 20 years before it was found in my bloodstream. My hepatologist proceeded to take a blood test and bingo, she caught my Hep after all those years. A biopsy also determined that I had compensated cirrhosis, which the Dr. explained to me that was the very begging stages of cirrhosis, advise to take Sovaldi. However, it was so expensive, thankfully I heard generic Indian sovaldi, In Jan 2017 I started the 12-weeks Indian generic sovaldi treatment course bought from , “I’ve read a lot of forums about the Sovaldi treatment because I was very worried the first time I had any treatment at all. In 4 weeks I was undetectable and at my request I was tested last month 18 months still undetectable! No side effects!” I’m very grateful!” And My friend recently started treatment & after 4 weeks virus is gone, however, the doctor said to complete course of 12-weeks. I hope it would be the same for everyone. We’re hoping if you can release the cheaper generic as soon as possible for this viral disease. There are dozens of poor people in several countries who can’t afford this costly treatment, who really needs this.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy